Terms: = Leukemia AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Prognosis
119 results:
1. The RAS-signaling-pathway-mutation-related prognosis in B-cell acute lymphoblastic leukemia: A report from South China children's leukemia group.
Li X; Lin S; Liao N; Mai H; Long X; Liu L; Wu B; Chen Q; Kong Q; Kong X; Liu L; Qin J; Fang J; Zhou D
Hematol Oncol; 2024 May; 42(3):e3265. PubMed ID: 38564328
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic implications of cGAS and STING gene expression in acute myeloid leukemia.
Chen Q; Hong Y; Chen W; Lin F; Zeng J; Huang Y; Zhang L; Yao J; Xu B
Exp Biol Med (Maywood); 2024; 249():10108. PubMed ID: 38510490
[TBL] [Abstract] [Full Text] [Related]
3. AML with RUNX1::RUNX1T1 Cooperating two Mutations Relapsed Quickly after Achieving CR.
XinhongYang ; Wu Y; Yang X; Wu X; Chen Y; Zhang R; Zhang Z
Clin Lab; 2024 Mar; 70(3):. PubMed ID: 38469780
[TBL] [Abstract] [Full Text] [Related]
4. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
[TBL] [Abstract] [Full Text] [Related]
5. Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML.
Shimony S; Bewersdorf JP; Shallis RM; Liu Y; Schaefer EJ; Zeidan AM; Goldberg AD; Stein EM; Marcucci G; Lindsley RC; Chen EC; Ramos Perez J; Stein A; DeAngelo DJ; Neuberg DS; Stone RM; Ball B; Stahl M
Leukemia; 2024 Apr; 38(4):762-768. PubMed ID: 38378841
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia].
Zhou ZY; Dai LMJ; Sha YQ; Qiu TL; Qin SC; Miao Y; Xia Y; Wu W; Tang HN; Xu W; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):917-923. PubMed ID: 38185521
[No Abstract] [Full Text] [Related]
7. NLRP3 inflammasome activation and symptom burden in kras-mutated CMML patients is reverted by IL-1 blocking therapy.
Hurtado-Navarro L; Cuenca-Zamora EJ; Zamora L; Bellosillo B; Such E; Soler-Espejo E; Martínez-Banaclocha H; Hernández-Rivas JM; Marco-Ayala J; Martínez-Alarcón L; Linares-Latorre L; García-Ávila S; Amat-Martínez P; González T; Arnan M; Pomares-Marín H; Carreño-Tarragona G; Chen-Liang TH; Herranz MT; García-Palenciano C; Morales ML; Jerez A; Lozano ML; Teruel-Montoya R; Pelegrín P; Ferrer-Marín F
Cell Rep Med; 2023 Dec; 4(12):101329. PubMed ID: 38118408
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical Analysis of Infants with Acute Lymphoblastic leukemia (18 cases)].
Li KL; Xiong H; Li H; Wang Z; Chen Z; Yang L; Lu WJ; Qi SS; Sun M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1670-1675. PubMed ID: 38071044
[TBL] [Abstract] [Full Text] [Related]
9. The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.
Yang J; Zhao L; Wu Y; Niu T; Gong Y; Chen X; Huang X; Liu J; Dai Y; Ma H
Cancer Med; 2023 Dec; 12(23):21111-21117. PubMed ID: 37937729
[TBL] [Abstract] [Full Text] [Related]
10. Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach.
Forghani-Ramandi MM; Mostafavi B; Bahavar A; Dehghankar M; Siami Z; Mozhgani SH
Virus Res; 2023 Dec; 338():199237. PubMed ID: 37832654
[TBL] [Abstract] [Full Text] [Related]
11. [Characteristics of genetic variants in 134 patients with Acute myeloid leukemia].
He M; Zhao X; Tian H; Zhang S; Zhao F; Zhang X; Wu T
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Oct; 40(10):1222-1227. PubMed ID: 37730221
[TBL] [Abstract] [Full Text] [Related]
12. S1P-S1PR3-RAS promotes the progression of S1PR3
Zhu D; Jiang T; Ma D; Zhang H; Zhang J; Lv W; Gong M; Wang H; Liu Z; Su H; Zeng L; Liu S; Tang S; Yang B; Tshavuka FI; Fu G; Liu Z; Peng D; Liu H; Yan Z; Cao Z; Zhao H; He TC; Yu J; Shu Y; Zou L
Leukemia; 2023 Oct; 37(10):1982-1993. PubMed ID: 37591940
[TBL] [Abstract] [Full Text] [Related]
13. Core-binding factor abnormalities involving chromosome 16 in acute myeloid leukaemia: prognostic and therapeutic implications.
Panigrahi C; Tikare N; Das PK; Padhi S
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37591621
[TBL] [Abstract] [Full Text] [Related]
14. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
[TBL] [Abstract] [Full Text] [Related]
15. NRAS
Pan L; Liang F; Chen X; Hao Z; Muyey DM; Chen X; Wang H
Ann Clin Lab Sci; 2023 May; 53(3):389-397. PubMed ID: 37437942
[TBL] [Abstract] [Full Text] [Related]
16. RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group.
Sendker S; Awada A; Domagalla S; Sendker M; Orhan E; Hoffmeister LM; Antoniou E; Niktoreh N; Reinhardt D; von Neuhoff N; Schneider M
Leukemia; 2023 Jul; 37(7):1435-1443. PubMed ID: 37188777
[TBL] [Abstract] [Full Text] [Related]
17. Impact of
Mustafa Ali MK; Williams MT; Corley EM; AlKaabba F; Niyongere S
Leuk Lymphoma; 2023 May; 64(5):962-971. PubMed ID: 37042657
[TBL] [Abstract] [Full Text] [Related]
18. [Analysis of 7 cases of pediatric acute myeloid leukemia with DEK-NUP214 fusion gene].
Li XL; Liu LP; Wan Y; Liu F; Chen X; Ren YY; Ruan M; Guo Y; Zhu XF; Yang WY
Zhonghua Er Ke Za Zhi; 2023 Apr; 61(4):357-362. PubMed ID: 37011983
[No Abstract] [Full Text] [Related]
19. Characteristics and clinical outcomes of patients with acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2).
Richard-Carpentier G; Rausch CR; Sasaki K; Hammond D; Morita K; Takahashi K; Tang G; Kanagal-Shamanna R; Bhalla K; Dinardo CD; Borthakur G; Pemmaraju N; Shpall EJ; Alousi A; Daver NG; Garcia-Manero G; Konopleva MY; Ravandi F; Kantarjian HM; Kadia TM
Haematologica; 2023 Sep; 108(9):2331-2342. PubMed ID: 36951163
[TBL] [Abstract] [Full Text] [Related]
20. A global study for acute myeloid leukemia with RARG rearrangement.
Zhu HH; Qin YZ; Zhang ZL; Liu YJ; Wen LJ; You MJ; Zhang C; Such E; Luo H; Yuan HJ; Zhou HS; Liu HX; Xu R; Li J; Li JH; Hao JP; Jin J; Yu L; Zhang JY; Liu LP; Zhang LP; Huang RB; Shen SH; Gao SJ; Wang W; Yan XJ; Zhang XY; Du X; Chu XX; Yu YF; Wang Y; Mi YC; Lu Y; Cai Z; Su Z; Taussig DC; MacMahon S; Ball ED; Wang HY; Welch JS; Yin CC; Borthakur G; Sanz MA; Kantarjian HM; Huang JY; Hu J; Chen SN
Blood Adv; 2023 Jul; 7(13):2972-2982. PubMed ID: 36799929
[TBL] [Abstract] [Full Text] [Related]
[Next]
